• 1
    Abehsira-Amar, O, Gilbert, M, Jolly, M, Theze, J, Jankovic, DTLj. IL-4 plays a dominant role in the differential development of th0 into Th1 and Th2 cells. J Immunol 1992: 148: 38209.
  • 2
    Akagi, K, Townley, RG. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma. J Allergy Clin Immunol 1989: 83: 7429.
  • 3
    Alam, R, Forsythe, PA, Lett-Brown, MA, Grant, JA. Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol 1989: 142: 39516.
  • 4
    Alam, R, Welter, JB, Forsythe, PA, Lett-Brown, MA, Grant, JA. Comparative effects of recombinant IL-1, -2, -3. -4 and -6, IFN-γ, granulocyte-macrophage-colony stimulating factor, tumor necrosis factor-α, and histamine-releasing factor on the secretion of histamine from basophils. J Immunol 1989: 142: 34315.
  • 5
    Arock, M, Mearle-Beral, H, Dugas, B, et al. IL-4 release by human leukemic and activated normal basophils. J Immunol 1993: 151: 14417.
  • 6
    Bascom, R, Pipkorn, U, Lichtenstein, LM, Naclerio, RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Am Rev Respir Dis 1988: 138: 40612.
  • 7
    Bascom, R, Wachs, M, Naclerio, RM, Pipkorn, U, Galli, SJ, Lichtenstein, LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pre-treatment. J Allergy Clin Immunol 1988: 81: 5809.
  • 8
    Baumgarten, CR, Nichols, RC, Naclerio, RM, Proud, D. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol 1986: 137: 13238.
  • 9
    Ben-Sasson, SZ, Le Gros, G, Conrad, DH, Finkelman, FD, Paul, WE. Cross-linking Fc receptors stimulates splenic non-B, non-T cells to secrete interleukin-4 and other lymphokines. Proc Natl Acad Sci U S A 1989: 87: 14215.
  • 10
    Bischoff, SC, De Weckal, Dahinden, CA. Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component c3a. Proc Natl Acad Sci U S A 1990: 87: 681317.
  • 11
    Bischoff, SC, Brunner, T, De Weck, AL, Dahinden, CA. Interleukin-5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990: 172: 157782.
  • 12
    Bochner, BS, Charles Worth, EN, Lichtenstein, LM, et al. Interleukin-1 is released at sites of cutaneous allergic reactions. J Allergy Clin Immunol 1990: 86: 8309.
  • 13
    Bochner, BS, Lichtenstein, LM. Mechanisms of basophil recruitment in allergic diseases. Clin Exp Allergy 1992: 22: 975.
  • 14
    Bochner, BS, McKelvey, AA, Sterbinsky, S, et al. IL-3 augments adhesiveness for endothelium and CD1 Ib expression in human basophils but not neutrophils. J Immunol 1990: 145: 18327.
  • 15
    Brindley, LL, Sweet, JM, Goetzl, EJ. Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest 1983: 72: 121823.
  • 16
    Brown, MA, Pierce, JH, Watson, CJ, Falco, J, Ihle, JN, Paul, WE. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987: 50: 80918.
  • 17
    Brunner, T, Heusser, CH, Dahinden, CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993: 177: 60511.
  • 18
    Burnet, FM. The probable relationship of some or all mast cells to the T-cell system. Cell Immunol 1977: 30: 35860.
  • 19
    Casolaro, V, Spadaro, G, Marone, G. Human basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990: 142: 110811.
  • 20
    Charlesworth, EN, Hood, AF, Soter, NA, Kagey-Sobotka, A, Norman, PS, Lichtenstein, LM. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989: 83: 151926.
  • 21
    Charlesworth, EN, Kagey-Sobotka, A, Schleimer, RP, Norman, PS, Lichtenstein, LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to antigen. J Immunol 1990: 146: 6716.
  • 22
    Charlesworth, EN, Massey, WA, Kagey-Sobotka, A, Norman, PS, Lichtenstein, LM. Effect of H, receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992: 262: 96470.
  • 23
    Chung, SW, Wong, PMC, Shen-Ong, G, Ruscetti, S, Ishizaka, T, Eaves, CJ. production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood 1986: 68: 107481.
  • 24
    Cohan, VL, Undem, BJ, Fox, CC, Adkinson, NF Jr, Lichtenstein, LM, Schleimer, RP. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 1989: 140: 9514.
  • 25
    Collins, JV, Wardlaw, AJ, Cromwell, O, Kay, AB. Mast cells and neutrophils in bronchoalveolar lavage from asthmatics. J Allergy Clin Immunol 1986: 77 (Suppl.): 209.
  • 26
    Columbo, M, Casolaro, V, Warner, JA, Macglashan, DW JR, Kagey-Sobotka, A, Lichtenstein, LM. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol 1990: 145: 385561.
  • 27
    Columbo, M, Horowitz, EM, Botana, LM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992: 149: 599608.
  • 28
    Conrad, DH, Bensasson, SZ, Le Gros, G, Finkelman, FD, Paul, WE. Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin-4 production by non-B, non-T cells. J Exp Med 1990: 171: 14971508.
  • 29
    Czarnetzkl, BM, Sterry, W, Bazin, H, Kalveram, KJ. Evidence that tissue mast cells derive from mononuclear phagocytes. Int Arch Appl Immunol 1982: 67: 448.
  • 30
    Dahinden, CA, Geiser, T, Brunner, T, et al. Monocyte chemotactic protein 3 is a most effective basophil and eosinophil-activating chemokine. J Exp Med 1994: 179: 7516.
  • 31
    Del Prete, G, Maggi, E, Parronchi, P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988: 140: 41938.
  • 32
    Dunsky, EH, Zweiman, B. The direct demonstration of histamine release in the skin using a skin chamber technique. J Allergy Clin Immunol 1978: 62: 12730.
  • 33
    Dvorak, AM. Morphologic and immunologic characterization of human basophils (1879–1985). J Immunol Immu-nopharmacol 1988: 8: 5083.
  • 34
    Findlay, SR, Lichtenstein, LM. Basophil “releasability” in patients with asthma. Am Rev Respir Dis 1980: 122: 539.
  • 35
    Flint, KC, Leung, KBP, Hudspith, BN, Brostoff, J, Pearce, FL, Johnson, NM. bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. BMJ 1985: 291: 9236.
  • 36
    Fox, CC, Dvorak, AM, Peters, SP, Kagey-Sobotka, A, Lichtenstein, LM. Isolation and characterization of human intestinal mucosal mast cells. J Immunol 1985: 135: 48391.
  • 37
    Gaddy, JN, Busse, WW. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis 1986: 134: 96974.
  • 38
    Gagnon, R, Akoum, A, Hebert, J. Lol p I-induced IL-4 and IFN-γ production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season. J Allergy Clin Immunol 1993: 91: 9506.
  • 39
    Galli, SJ, Lichtenstein, LM. Biology of mast cells and basophils. In: Middleton, E, Reed, CE, Ellis, EF, Adkinson, NFJr, Yunginger, JW, Eds. Allergy: principles and practice. St Louis , MO : CV Mosby, 1988: 10634.
  • 40
    Gibson, PG, Dolovich, J, Girgis-Gabardo, A, et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils, and their progenitors. Clin Exp Allergy 1990: 20: 6618.
  • 41
    Gibson, PG, Manning, PJ, O'Byrne, PM, et al. Allergen-induced asthmatic responses: relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils. And their progenitors. Am Rev Respir Dis 1991: 143: 3315.
  • 42
    Glovsky, MM, Hugli, TE, Ishizaka, T, Lichtenstein, LM, Erikson, BW. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest 1979: 64: 80411.
  • 43
    Gleich, GJ. The late phase of the immunoglobulin E-mediated reactions: a link between anaphylaxis and common allergic disease J Allergy Clin Immunol 1982: 70: 1609.
  • 44
    Grant, JA, Alam, R, Lett-Brown, MA. Histamine-releasing factors and inhibitors. Historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991: 88: 68393.
  • 45
    Guo, C-B, Liu, MC, Galli, SJ, Bochner, BS, KageySobotka, A, Lichtenstein, LM. Identification of IgE-bearing cells in the late phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1993: 10: 38490.
  • 46
    Guydon, LD, Kagey-Sobotka, A, Lichtenstein, LM, et al. Relationships between peripheral blood basophil releasability and lung physiology following antigen challenge in asthma. Am J Respir Crit Care Med 1994: 149: A962.
  • 47
    Hirai, K, Morita, Y, Misaki, Y, et al. Modulation of human basophil histamine release by hematopoietic growth factors. J Immunol 1988: 141: 395764.
  • 48
    Hirai, K, Yamaguchi, M, Misaki, Y, et al. Enhancement of human basophil histamine release by interleukin-5. J Exp Med 1990: 172: 15258.
  • 49
    Iliopoulos, O, Baroody, F, Naclerio, RM, Bochner, BS, Kagey-Sobotka, A, Lichtenstein, LM. Histamine containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992: 148: 22238.
  • 50
    Ishizaka, T, Debernardo, R, Tomioka, H, Lichtenstein, LM, Ishizaka, K. Identification of basophil granulocytes as a site of allergic histamine release. J Immunol 1972: 108: 10004.
  • 51
    Lawrence, ID, Warner, JA, Cohan, VL, Hubbard, WC, Kagey-Sobotka, A, Lichtenstein, LM. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 1987: 139:30629.
  • 52
    Liu, MC, Bleecker, ER, Lichtenstein, LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airway of subjects with mild asthma. Am Rev Respir Dis 1990: 142: 12632.
  • 53
    Liu, MC, Hubbard, WC, Proud, D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991: 144: 518.
  • 54
    Kagey-Sobotka, A, Macdonald, SM, Fox, C, Warner, JA, Lichtenstein, LM. In vitro and in vivo studies of human basophils and mast cells: mediators, secretogogues, and pharmacology. In: Proceedings of the First Capri Conference on Clinical Immunology. Toronto : BC Decker. 1989: 3947.
  • 55
    Kaplan, AP, Haak-Frendscho, M, Fauci, A, Dinarello, C, Halbert, E. A Histamine releasing factor from activated human mononuclear cells. J Immunol 1985: 135: 202732.
  • 56
    Kauffman, F, Neukirch, F, Annesi, I, Korobaeff, M, Dore, M-F, Lellouch, J. Relation of perceived nasal and bronchial hyperresponsiveness to FEV, basophil counts, and methacholine response. Thorax 1988: 43: 45661.
  • 57
    Kirloy, JG, Hargreave, FE, Gleich, GJ, O'Byrne, PM. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987: 136: 37983.
  • 58
    Kirshenbaum, AS, Goff, JP, Kessler, SW, Mican, JM, Zsebo, KM, Metcalfe, DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34 + pluripotent progenitor cells. J Immunol 1992: 148: 7727.
  • 59
    Koshino, T, Teshima, S, Fukushima, N, et al. Identification of basophils by immunohistochemistry in the airways of postmortem cases of fatal asthma. Clin Exp Allergy 1993: 23: 91925.
  • 60
    Kuna, P, Reddigari, SR, Schall, TJ, Rucinski, D, Sadick, M, Kaplan, AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993: 150: 193243.
  • 61
    Le Gros, G, BenSasson, SZ, Conrad, DH, et al. IL-3 promotes production of IL-4 by splenic non-B, non-T cells in response to Fc receptor cross-linkage. J Immunol 1990: 145: 25006.
  • 62
    Lichtenstein, LM, Norman, PS, Winkenwerder, WL. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 1968: 44: 51424.
  • 63
    Liu, MC, Proud, D, Lichtenstein, LM, et al. Human lung macrophage-derived histamine releasing activity is due to an IgE-binding factor(s). J Immunol 1986: 136: 258895.
  • 64
    MacDonald, SM, Lichtenstein, LM, Proud, D, et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987: 139: 50612.
  • 65
    MacDonald, SM, Schleimer, RP, Kagey-Sobotka, A, Gillis, S, Lichtenstein, LM. Recombinant IL-3 induces histamine release from human basophils. J Immunol 1989: 142: 352732.
  • 66
    MacGlashan, DW JR, Botana, L. Biphasic Ca ++ responses in human basophils: evidence that the initial transient elevation associated with mobilization of intracellular calcium is an insufficient signal for degranulation. J Immunol 1993: 150: 98091.
  • 67
    MacGlashan, DW JR, Warner, JA. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J Leukoc Biology 1991: 49: 2940.
  • 68
    MacGlashan, DW JR, White, JM, Huang, S-K, Ono, SJ, Schroeder, JT, Lichtenstein, LM. Secretion of interleukin-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1993: 152: 300616.
  • 69
    Massey, WA, Friedman, B, Kato, M, et al. Appearance of IL-3 and GM-CSF activity at allergen-challenged cutaneous late-phase reaction sites. J Immunol 1993: 150: 108492.
  • 70
    Massey, W, Guo, CB, Dvorak, AM, et al. Human uterine mast cells: isolation, purification, characterization, ultra-structure and pharmacology. J Immunol 1991: 47: 16217.
  • 71
    Massey, WA, Kato, M, Bochner, BS, et al. Inhibition of late phase reaction areas, inflammatory cell appearance, and local cytokine production by topical steroid treatment in a cutaneous model of allergic inflammation. J Allergy Clin Immunol (Submitted).
  • 72
    Massey, WA, Randall, TC, Kagey-Sobotka, A, et al. Recombinant human IL-1-alpha and -1-beta potentiate IgE-mediated histamine release from human basophils. J Immunol 1989: 142: 187580.
  • 73
    Moser, R, Fehr, J. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992: 149: 14328.
  • 74
    Mossman, TR, Cherwinski, H, Bond, MW, Giedlin, MA, Coffman, RL. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted protein. J Immunol 1986: 136: 234857.
  • 75
    Naclerio, RM, Proud, D, Togias, AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985: 313: 6570.
  • 76
    Nguyen, KL, Gillis, S, Macglashan, DW Jr. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990: 85: 10209.
  • 77
    Okuda, M, Ohtsuka, H. Basophilic cells in allergic nasal secretions. Arch Otorhinolaryngol 1977: 214: 2839.
  • 78
    Orchard, MA, Kagey-Sobotka, A, Proud, D, Lichtenstein, LM. Basophil histamine release induced by a substance from stimulated human platelets. J Immunol 1986: 136: 22404.
  • 79
    Parkin, JL, McKenna, RW, Brunning, RD. Ultrastructural features of basophil and mast cell granulopoiesis in blastic phase Philadelphia chromosome positive leukemia. J Natl Cancer Inst 1980: 65: 53446.
  • 80
    Paul, WE, Seder, RA, Plaut, M. Lymphokine and cytokine production by fcɛRI positive cells. Adv Immunol 1993: 53: 129.
  • 81
    Pepys, J, Davies, RJ, Breslin, ABX, Hendrick, DJ, Hutchcroft, BJ. The effect of inhaled beclomethasone dipropionate (Becotide) and sodium cromoglycate on asthmatic reaction to provocation tests. Clin Allergy 1974: 4: 1324.
  • 82
    Piccinni, M-P, Macchia, D, Parronchi, P, et al. Human bone marrow non-B, non-T cells produce interleukin-4 in response to cross-linkage of Fcɛ and Fcγ receptors. Proc Natl Acad Sci U S A 1991: 88: 865660.
  • 83
    Pin, I, Gibson, PG, Kolendowicz, R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992: 47: 259.
  • 84
    Pipkorn, U, Proud, D, Lichtenstein, LM, et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987: 80: 95761.
  • 85
    Plaut, M, Pierce, JH, Watson, CJ, Hanley, HJ, Nordan, RP, Paul, WE. Mast cell lines produce lymphokines in response to cross-linkage of fcɛRI or to calcium ionophores. Nature 1989: 339: 647.
  • 86
    Sampson, D, Archer, GT. Release of histamine from human basophils. Blood 1967: 29: 72236.
  • 87
    Sampson, HA, Broadbent, KR, Bernhisel-Broadbent, J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989: 321: 22832.
  • 88
    Sanderson, CJ, Campbell, HD, Young, IG. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effect on human and mouse B cells. Immunol Rev 1988: 102: 29.
  • 89
    Schleimer, RP, Derse, CP, Friedman, B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989: 143: 131017.
  • 90
    Schleimer, RP, Lichtenstein, LM, Gillespie, E. Inhibition of basophil histamine release by antiinflammatory steroids. Nature 1981: 292: 4545.
  • 91
    Schleimer, RP, Sterbinsky, SA, Kiser, J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992: 148: 108692.
  • 92
    Schroeder, JT, MacGlashan, DW JR, Kagey-Sobotka, A, White, JM, Lichtenstein, LM. Ige-dependent IL-4 secretion by human basophils: the relationship between cytokine production and histamine release in mixed leukocyte cultures. J Immunol 1994: 153: 180817.
  • 93
    Schulman, ES, MacGlashan, DW JR, Peters, SP, Schleimer, RP, Newball, HH, Lichtenstein, LM. Human lung mast cells: purification and characterization. J Immunol 1982: 129: 26627.
  • 94
    Schwartz, L, Huff, T. Biology of mast cells and basophils. In: Middleton, E, Reed, CE, Ellis, EF, Adkinson, NFJR, Yunginger, JW, eds. Allergy: principles and practice. St Louis , MO : CV Mosby, 1992: 13568.
  • 95
    Seder, RA, Paul, WE, Dvorak, AM, et al. Mouse splenic and bone marrow cell populations that express high affinity Fcɛ receptors and produce interleukin-4 are highly enriched in basophils. Proc Natl Acad Sci U S A 1991: 88: 28359.
  • 96
    Siraganian, RP, Hook, WA. Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction. J Immunol 1976: 116: 63946.
  • 97
    Siraganian, RP, Hook, WA. Mechanism of histamine release by formyl methionine containing peptides. J Immunol 1977: 119: 207883.
  • 98
    Solley, GO, Gleich, GJ, Jordan, RE, Schroeter, AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976: 58: 40820.
  • 99
    Sparrow, D, O'Connor, GT, Rosner, B, Weiss, ST. Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: the normative aging study. Am J Respir Crit Care Med 1993: 149: 919.
  • 100
    Subramanian, N, Bray, MA. Interleukin-1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987: 138: 2715.
  • 101
    Swain, SL, Weinberg, AD, English, M, Huston, G. IL-4 directs the development of Th2–like helper effectors. J Immunol 1990: 145: 37963806.
  • 102
    Thueson, DO, Speck, LS, Lett-Brown, MA, Grant, JA. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 1979: 123: 62631.
  • 103
    Tomioka, M, Ida, S, Shindoh, Y, Ishihara, T, Takishima, T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984: 129: 10005.
  • 104
    Tung, R, Lichtenstein, LM. In vitro histamine release from basophils of asthmatic and atopic individuals in D2O. J Immunol 1982: 128: 206772.
  • 105
    Valent, P. The riddle of the mast cell: kit(CD117)-ligand as the missing link Immunol Today 1994: 15: 11114.
  • 106
    Valent, P, Besemer, J, Muhm, M, Majdic, O, Lechner, K, Bettelhein, P. Interleukin-3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA 1989: 86: 55426.
  • 107
    Van Der Donk, AMM, Blok, W, Mkok, PT, Bruijnzeel, PLB. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects. Prostaglandins Leukot Essent Fatty Acids 1991: 44: 1117.
  • 108
    Vercelli, D, Geha, RS. Regulation of IgE synthesis in humans: a tale of two signals. J Allergy Clin Immunol 1991: 88: 28595.
  • 109
    Vercelli, D, Jabara, HH, Arai, K-I, Geha, RS. Induction of human IgE requires interleukin-4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989: 169: 12951307.
  • 110
    Warner, JA, MacGlashan, DW Jr. signal transduction events in human basophils: a comparative study of the role of protein kinase-C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. J Immunol 1990: 145: 18971905.
  • 111
    Warner, JA, Pienkowski, MM, Plaut, M, Norman, PS, Lichtenstein, LM. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986: 136: 25837.
  • 112
    Wodnar-Filipowicz, A, Heusser, CH, Moroni, C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989: 339: 1502.
  • 113
    Zucker-Franklin, D. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 1980: 56: 53440.